Momordicine-I, a Bitter Melon Bioactive Metabolite, Displays Anti-Tumor Activity in Head and Neck Cancer Involving c-Met and Downstream Signaling

SIMPLE SUMMARY: The incidence of head and neck cancer (HNC), one of the most aggressive cancers, is increasing rapidly globally. Conventional and targeted therapies show limited success with several undesirable side effects. Thus, there is a critical clinical need to identify additional alternative...

Descripción completa

Detalles Bibliográficos
Autores principales: Sur, Subhayan, Steele, Robert, Isbell, T. Scott, Venkata, Kalyan Nagulapalli, Rateb, Mostafa E., Ray, Ratna B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003975/
https://www.ncbi.nlm.nih.gov/pubmed/33801016
http://dx.doi.org/10.3390/cancers13061432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003975/
https://www.ncbi.nlm.nih.gov/pubmed/33801016
http://dx.doi.org/10.3390/cancers13061432

Ejemplares similares